EARLY MODELLING OF THE COST-EFFECTIVENESS OF STRATIFIED MEDICINE IN COPD

被引:0
|
作者
Hoogendoorn, M. [1 ]
Ramos, Corro, I [1 ]
Baldwin, M. [2 ]
Guix, Gonzalez-Rojas N. [3 ]
Rutten-van Molken, M. [1 ]
机构
[1] Erasmus Univ, Rotterdam, Netherlands
[2] Boehringer Ingelheim Germany, Ingelheim, Germany
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
关键词
D O I
10.1016/j.jval.2017.08.1482
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRS26
引用
收藏
页码:A644 / A644
页数:1
相关论文
共 50 条
  • [1] Modeling the cost-effectiveness of stratified medicine in COPD
    Hoogendoorn, Martine
    Ramos, Isaac Corro
    Rutten-van Molken, Maureen
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] Cost-effectiveness modelling
    Barlow, DH
    HUMAN REPRODUCTION, 2001, 16 (12) : 2479 - 2480
  • [3] COST-EFFECTIVENESS IN MEDICINE
    CARR, DT
    ARCHIVES OF ENVIRONMENTAL HEALTH, 1970, 21 (01): : 1 - &
  • [4] COST-EFFECTIVENESS IN MEDICINE
    VU, HT
    JOURNAL OF FAMILY PRACTICE, 1995, 41 (02): : 198 - 198
  • [5] COST-EFFECTIVENESS OF CASE DETECTION STRATEGIES FOR THE EARLY DETECTION OF COPD
    Johnson, K.
    Sadatsafavi, M.
    Adibi, A.
    Lynd, L. D.
    Harrison, M.
    VALUE IN HEALTH, 2020, 23 : S352 - S352
  • [6] Cost-effectiveness of early assisted discharge for COPD exacerbations in the Netherlands
    Goossens, Lucas
    Utens, Cecile
    Smeenk, Frank
    van Schayck, Onno
    Rutten-van Molken, Maureen
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in The Netherlands
    Goossens, Lucas M. A.
    Utens, Cecile M. A.
    Smeenk, Frank W. J. M.
    van Schayck, Onno C. P.
    van Vliet, Monique
    van Litsenburg, Walter
    Braken, Maria W.
    Rutten-van Molken, Maureen P. M. H.
    VALUE IN HEALTH, 2013, 16 (04) : 517 - 528
  • [8] Modelling cost-effectiveness in osteoporosis
    Kanis, John A.
    Adams, Judith
    Borgstrom, Fred
    Cooper, Cyrus
    Jonsson, Bengt
    Preedy, Danielle
    Selby, Peter
    Compston, Juliet
    BONE, 2008, 43 (01) : 215 - 216
  • [9] Modelling for cost-effectiveness analysis
    Russell, LB
    STATISTICS IN MEDICINE, 1999, 18 (23) : 3235 - 3244
  • [10] THE COST-EFFECTIVENESS OF ROFLUMILAST FOR COPD IN SWEDEN
    Engstrom, A.
    VALUE IN HEALTH, 2011, 14 (07) : A494 - A494